Observation of de Novo Bladder Dysfunction under Treatment with Her2-neu Antibodies

Publisher： Karger

E-ISSN： 1423-0399|86|1|80-84

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.86, Iss.1, 2010-11, pp. : 80-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Values of p53 and HER-2/neu Coexpression in Invasive Bladder Cancer in Taiwan

By  

Urologia Internationalis, Vol. 71, Iss. 3, 2003-09 ,pp. : 262-270

Karger

Access to resources Recommend Favorite

Change in HER-2/neu Status from Negative to Positive following Treatment in Breast Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-01 ,pp. : 19-24

Karger

Access to resources Recommend Favorite

HER2: The Neu Prognostic Marker for Breast Cancer

By Tsongalis Gregory J.   Ricci Jr. Andrew  

Critical Reviews in Clinical Laboratory Sciences, Vol. 38, Iss. 2, 1998-03 ,pp. : 167-182

Informa Healthcare

Access to resources Recommend Favorite

HER2/neu vaccines in breast cancer

By Khoo Steven   Ponniah Sathibalan   Peoples George E  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 217-223

Future Medicine

Access to resources Recommend Favorite

Targeting Her-2/neu in Breast Cancer: As Easy as This!

By  

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 150-157

Karger

Access to resources Recommend Favorite